32 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #Infections #OIs ... HIVAIDS #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #Infections #OIs ... HIVAIDS #IDSA #management ... #pharmacology
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
Treatment • Invasive pulmonary ... • Aspergillus infections ... of eye Infectious ... Aspergillosis #Treatment #management ... #pharmacology #
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
patients with Opportunistic ... Infections • ... Pulmonary TB and ... count <50 • Pulmonary ... #Infections #management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... 100 cells/mm3 g/mL ... Prevention #Treatment #management ... #opportunistic ... #pharmacology
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Blood Pressure, Pulmonary ... Dobutamine 2-20 mcg ... Epinephrine 0-20 mcg ... Properties #Table #Pharmacology ... #Effect #Management
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Papillomavirus Infections ... of mode of HIV infection ... Prevention #Treatment #management ... #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Bacterial Enteric Infections ... if MIC<0.12 ug/ml ... Prevention #Treatment #management ... #opportunistic ... #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Isospora belli Infection ... General Management ... Prevention #Treatment #management ... #opportunistic ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
suspension 4–6 mL ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology